Safe Trial Templates — Participant Consent & Risk Notice

Participant Consent & Risk Notice — Template

Use this template to create a clear, concise participant notice and consent record for low-risk technology trials and prototypes. The goal is to set expectations, document consent, describe monitoring and mitigation, and define rollback and decision points so teams can learn quickly without creating avoidable harm, privacy incidents, or bad optics. Adapt all sections to your organizational policies, local regulations, and the specific pilot context. This is a practical starting point, not legal or medical advice.

Template Fields (fill these before sharing)

• Trial name / code: [TRIAL_NAME]
• Sponsor / team: [TEAM_OR_ORG]
• Principal contact: [NAME, ROLE, EMAIL, PHONE]
• Pilot dates: [START_DATE] – [END_DATE]
• Location / environment: [ON_PREMISES / REMOTE / FIELD / PRODUCT_BETA]
• Participant group: [EMPLOYEES / CUSTOMERS / PUBLIC / VOLUNTEERS]
• Purpose: One-sentence description of what the trial is testing: [PURPOSE_STATEMENT]
• Scope & limits: Describe what is and is not part of the trial, including any explicit exclusions: [SCOPE_NOTE]

Participant-Facing Notice (clear, short — use for sign or acknowledgement)

Use plain language. Keep it short enough for participants to read easily and keep technical detail below in an appendix or internal documentation.

[TRIAL_NAME] is a limited pilot run by [TEAM_OR_ORG] to evaluate [brief purpose]. Participation is voluntary. If you participate, you will:

• Perform or experience: [what participation involves—tasks, duration, frequency].
• Allow collection of: [list data types—e.g., usage logs, survey responses, audio, images].
• Be monitored for safety and performance. Any issues will be handled by [contact & escalation].

Known risks are: [brief list of reasonably expected low risks]. Mitigations in place include: [brief list]. You may opt out at any time by contacting [contact] or using [opt-out method]. Your data will be handled as described below.

If you agree to participate, please sign below or indicate consent electronically. This pilot is not a substitute for professional medical, legal or safety advice.

Consent Wording (formal brief text you can paste into forms)

I have read the Participant Notice for [TRIAL_NAME]. I understand the purpose and scope of the pilot, the data that will be collected, the expected low risks and mitigations, and my right to withdraw at any time without penalty. I consent to participate under these terms.

Data Collected & Use (explicit, specific)

• Types of data: [e.g., usage metrics, screenshots, device telemetry, survey answers, timestamps, error logs]
• Purpose of collection: [e.g., model improvement, usability analysis, performance testing]
• Who will access data: [roles or teams—e.g., engineering, research, safety officer]
• Storage & retention: [location, retention period, access controls]
• Anonymization & de-identification steps: [methods, e.g., remove names, aggregate results, hash identifiers]
• Third-party sharing: [any vendors, processors—be explicit; note contracts in place]

Expected Risks & Mitigations

List reasonably expected low-probability impacts and what is being done to reduce them. Examples:

• Privacy risk: inadvertent collection of personal info. Mitigation: limit fields collected, anonymize within 48 hours, restrict access.
• Usability confusion: participants misunderstand the system. Mitigation: clear instructions, on-call support, immediate opt-out.
• Service disruption: trial causes temporary outages. Mitigation: sandbox environment, canary rollout, rollback plan.
• Reputational risk: unexpected behavior visible externally. Mitigation: avoid public-facing exposure until safety checks passed; communications plan.

Monitoring, Logging & Reporting

Define who monitors the trial, how issues are reported, and response timelines.

• Monitoring owner: [NAME, ROLE]
• Monitoring tools & frequency: [e.g., automated alerts, daily review, manual spot checks]
• Incident reporting: how participants report problems (email/phone/form) and expected response time (e.g., within 24 hours)
• Escalation path: [who is notified when threshold exceeded — team lead, safety officer, legal]

Rollback & Termination Plan (actionable and owned)

Make rollback steps explicit and testable. Include triggers, owners, and communications.

• Rollback trigger examples: sustained error rate > [X%] for [Y minutes], verified data leak, safety incident, regulatory concern, participant harm report.
• Rollback owner: [NAME, ROLE] — authorized to pause or terminate the trial immediately.
• Rollback actions: e.g., disable feature flag, revert to previous release, revoke access tokens, isolate dataset.
• Post-rollback steps: capture logs, notify affected participants, convene review meeting within [Z business days].
• Communications: internal notification list and template, participant notification template (if applicable), external PR/legal contact if public exposure.

Decision Points & Metrics

Specify concrete metrics that will guide decisions and the cadence of review.

• Primary success metric(s): [e.g., task completion rate, accuracy, time savings]
• Safety / risk metrics: [e.g., number of incidents, privacy complaints, error rate]
• Review cadence: [e.g., daily standups for first 3 days, weekly review meeting]
• Stop / escalate conditions: numeric thresholds or qualitative triggers tied to rollback actions above.

Monitoring Checklist (copy into operations playbook)

• Confirm participant consent recorded for each participant.
• Ensure telemetry collection is limited to approved fields.
• Verify anonymization pipeline is operational.
• Review alert thresholds are configured and tested.
• Ensure rollback procedures are executable by the owner (practice if possible).
• Confirm communications templates are ready.

Tailoring Guidance: Internal Pilots vs External Participants

Language and controls differ by audience.

• Internal pilots: participants may be employees with existing contractual relationships. Still document consent, allow opt-out, and consider additional approvals (HR, security). Emphasize limited scope and internal-use-only data handling. Avoid assuming implied consent.
• External participants: use clearer standalone consent forms, explicit data processing descriptions, and obtain legal review for any third-party processors. Consider compensation or incentives and how they affect consent.

Sample Minimal Internal Consent (short form)

"I understand that I am participating voluntarily in the [TRIAL_NAME] pilot run by [TEAM_OR_ORG]. I agree to the collection of the data types described in the Participant Notice for the stated purpose, and I understand I can withdraw at any time by contacting [CONTACT]."

Sample External Participant Consent (short form)

"By signing below I consent to participate in [TRIAL_NAME]. I understand what participation involves, the data to be collected and how it will be used, who will have access, and that I may withdraw at any time. My questions have been answered and I have received a copy of this notice."

Signatures / Acknowledgement

Provide either physical signature lines or an electronic acknowledgement mechanism.

Participant name: ___________________   Date: ___________

Participant signature / checkbox (electronic): ___________________

Team contact: ___________________   Role: ___________   Date: ___________

Legal, Privacy & Compliance Notes

Require a legal and data-privacy review when:

• Personal data beyond basic identifiers will be collected.
• Data will be shared with third parties or processed internationally.
• The pilot could affect regulated activities (health, finance, minors, safety-critical systems).

Document approvals and retain review records alongside the trial file.

Appendix: Internal Documentation to Maintain

• Detailed trial design and architecture diagram
• Data map and retention schedule
• Monitoring logs and incident reports
• Rollback runbook and proofs of execution
• Post-trial evaluation and lessons learned

Reminder: This template is a starting point. Adapt wording, thresholds, and procedures to your context and obtain legal or safety sign-off where required.